These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Transsphenoidal hypophysectomy for pituitary tumours. Dalton G Proc R Soc Med; 1974 Sep; 67(9):885-9. PubMed ID: 4431803 [No Abstract] [Full Text] [Related]
43. Dural invasion by pituitary tumours. Shaffi OM; Wrightson P N Z Med J; 1975 Apr; 81(538):386-90. PubMed ID: 1057087 [TBL] [Abstract][Full Text] [Related]
44. [Secondary osteoporosis in endocrine diseases]. Kann PH Dtsch Med Wochenschr; 2005 Jan; 130(4):165-70. PubMed ID: 15662584 [No Abstract] [Full Text] [Related]
45. An audit of outcome of treatment in acromegaly. Bates AS; Van't Hoff W; Jones JM; Clayton RN Q J Med; 1993 May; 86(5):293-9. PubMed ID: 8327647 [TBL] [Abstract][Full Text] [Related]
47. [The role of hypertensive-hydrocephalic manifestations in the genesis of neurologic symptoms in Itsenko-Cushing disease and Itsenko-Cushing syndrome]. Soskin LS; Gincherman EZ; Balakhovskaia MI Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(5):666-70. PubMed ID: 5998824 [No Abstract] [Full Text] [Related]
48. Treatment outcomes and mortality of 94 patients with acromegaly. Trepp R; Stettler C; Zwahlen M; Seiler R; Diem P; Christ ER Acta Neurochir (Wien); 2005 Mar; 147(3):243-51; discussion 250-1. PubMed ID: 15627919 [TBL] [Abstract][Full Text] [Related]
49. Adrenalectomy in Cushing's disease. A long-term follow-up. Ernest I; Ekman H Acta Endocrinol Suppl (Copenh); 1972; 160():3-41. PubMed ID: 4336708 [No Abstract] [Full Text] [Related]
50. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198 [TBL] [Abstract][Full Text] [Related]
51. Clinical pituitary disorders. Ezrin C Bull Los Angeles Neurol Soc; 1977; 42(3-4):81-91. PubMed ID: 227504 [TBL] [Abstract][Full Text] [Related]
52. Pituitary apoplexy in acromegaly followed by partial pituitary insufficiency. Jacobi JD; Fishman LM; Daroff RB Arch Intern Med; 1974 Sep; 134(3):559-61. PubMed ID: 4853653 [No Abstract] [Full Text] [Related]
54. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]
55. [Case presentation: diencephalic and pituitary diseases]. Horumon To Rinsho; 1982; Suppl():8-98. PubMed ID: 7183421 [No Abstract] [Full Text] [Related]
56. Syndrome of hypopituitarism and acromegaly; two case reports. SUMMERS VK; MIROUZE J Presse Med (1893); 1957 May; 65(36):848. PubMed ID: 13441572 [No Abstract] [Full Text] [Related]
57. Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome? SEIP M Acta Paediatr (Stockh); 1959 Nov; 48():555-74. PubMed ID: 14444642 [No Abstract] [Full Text] [Related]
58. [Endocrine skin syndrome]. KUHNAU WW Z Haut Geschlechtskr; 1959 Mar; 26(6):165-70. PubMed ID: 13648549 [No Abstract] [Full Text] [Related]